News for Agent

Daily business news: funding, M&A, launches

Earnings & Results

BrightSpring Health Services to Report Q3 Earnings With 16.1% Revenue Growth Expected

By ·

Key takeaways

  • BrightSpring Health Services will report Q3 earnings before the market opens on Friday.
  • Analysts expect revenue to grow 16.1% year on year, down from 28.2% in the same quarter last year.
  • BrightSpring reported $3.87 billion in revenue last quarter, up 23% year on year.
  • The company sold its ResCare Community Living business to Sevita for $835 million, a deal that closed March 31, 2026.

BrightSpring Health Services will report third-quarter earnings before the market opens on Friday, with analysts expecting revenue to grow 16.1% year on year, down from 28.2% in the same quarter last year, FinancialContent Business Page reported. BrightSpring is an integrated home- and community-based healthcare platform operating across all 50 U.S. states, providing pharmacy solutions and provider services to more than 465,000 patients daily.

BrightSpring's Q3 Revenue Expectations

Analysts covering BrightSpring have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings, according to FinancialContent. BrightSpring has missed Wall Street's revenue estimates multiple times over the last two years.

Last quarter, BrightSpring beat analysts' revenue expectations, reporting revenues of $3.87 billion, up 23% year on year. The company also beat analysts' EPS estimates, and its full-year revenue guidance slightly topped analysts' expectations.

Among peers in the healthcare providers and services segment, Chemed delivered year-on-year revenue growth of 10.6%, beating analysts' expectations by 0.9%, and Elevance Health reported flat revenue, topping estimates by 3.1%. Chemed traded up 4.9% following its results, while Elevance Health was up 1.2%.

BrightSpring's Divestiture and Board Addition

According to akta.pro company records, BrightSpring sold its ResCare Community Living business to Sevita for $835 million, a transaction that closed March 31, 2026, following an FTC consent order requiring divestiture of 126-128 intermediate care facilities. The same records show BrightSpring appointed Dr. Nigam H. Shah, Stanford Professor of Medicine and Biomedical Data Science and Chief Data Scientist at Stanford Healthcare, to its Board of Directors effective June 11, 2026. BrightSpring completed multiple secondary offerings in October 2025, March 2026 and June 2026 that reduced KKR affiliate ownership below 15% as of June 2026.

BrightSpring's Recent Deal Activity

In August 2025, BrightSpring acquired 107 home health branches from Amedisys and LHC Group in a $239 million transaction contingent on UnitedHealth's acquisition of Amedisys closing, according to akta.pro records. The acquired locations generated $345 million in full-year pro forma revenue in 2025. In February 2026, WellSky expanded its partnership with Adoration Home Health, a BrightSpring subsidiary, to extend clinical coding and documentation advisory services to additional Adoration locations.

BrightSpring's Dividend Payment Date

BrightSpring declared a quarterly dividend of $0.8438 per share, payable November 1 to shareholders of record October 15, Ticker Report reported.

Companies in this story

Sources

Machine-readable: Markdown · JSON